Edesa Biotech Inc (EDSA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $25.54M
Last updated: Nov 17, 2026 at 4:26 PM ET
Edesa Biotech Inc (EDSA) Statistics
Edesa Biotech (EDSA) has a market cap of $25.54M and an enterprise value of $15.20M. It kept -27695.45% of revenue as net income over the last 12 months. Its share count is up 28.26% from a year earlier.
Total Valuation
Enterprise value is 40.46% below the market cap, as cash exceeds debt.
| Market Cap | $25.54M |
|---|---|
| Enterprise Value | $15.20M |
| Latest price (Nov 17, 2026) | $1.96 |
Key Dates
The next earnings report is expected on Dec 10, 2026, covering the quarter ending Sep 30, 2026.
| Next Earnings Date | Dec 10, 2026 (expected) |
|---|---|
| Last Earnings Date | Aug 13, 2026 |
| Fiscal Year End | September |
Valuation Ratios
| P/B Ratio | 2.0x |
|---|---|
| P/TBV Ratio | 2.6x |
Price Statistics
The stock is up 12.32% over 52 weeks and trades 38.17% below its 50-day average.
| Beta (1Y) | 0.00 |
|---|---|
| 52-Week Change | +12.32% |
| 1-Month Change | -29.50% |
| 3-Month Change | -65.91% |
| 6-Month Change | -83.60% |
| 5-Year Change | -95.53% |
| 10-Year Change | -99.58% |
| Total Return (1Y) | +12.32% |
| Total Return (3Y CAGR) | -13.32% |
| Total Return (5Y CAGR) | -46.84% |
| Return vs SPY (1Y) | +1.08% |
| Max Drawdown (1Y) | -89.66% |
| Max Drawdown (3Y) | -89.66% |
| Sharpe Ratio (1Y) | 0.07 |
| Correlation with SPY (1Y) | 0.00 |
| 50-Day Average | $3.17 |
| 200-Day Average | $5.70 |
| 52-Week Range | $0.72 to $20.32 |
| RSI (14 Days) | 34.5 |
| Average Volume (20 Days) | 4.50M |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 2.76x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 2.76x |
|---|---|
| Quick Ratio | 2.76x |
| Debt / Equity | 0.00x |
Returns and Efficiency
Return on equity is -160.05% and return on assets is -110.85% over the last 12 months.
| Return on Equity (ROE) | -160.05% |
|---|---|
| Return on Assets (ROA) | -110.85% |
| Asset Turnover | 0.00x |
| Receivables Turnover | 0.00x |
Scores
EDSA has an Altman Z-Score of -8.95, in the distress zone below 1.81, and a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.
Altman Z-ScoreDistress below 1.81Safe above 2.99
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Altman Z-Score | -8.95 |
|---|---|
| Altman Z Zone | Distress |
| Piotroski F-Score | 2 of 9 |
| Piotroski Strength | Weak |
Income Statement
Revenue was $50.92K over the last 12 months.
| Revenue | $50.92K |
|---|---|
| Gross Profit | -$102.84K |
| Operating Income | -$14.63M |
| Pretax Income | -$14.10M |
| Net Income | -$14.10M |
| Reported EPS (TTM) | -$1.69 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 69.26% of the $12.72M in total assets.
| Cash and Equivalents | $10.33M |
|---|---|
| Total Debt | $0 |
| Net Cash | $10.33M |
| Net Cash Per Share | $1.15 |
| Working Capital | $6.87M |
| Shareholder Equity | $8.81M |
| Book Value Per Share | $0.98 |
| Tangible Book Value | $6.91M |
| Tangible Book Per Share | $0.77 |
| Total Assets | $12.72M |
| Total Liabilities | $3.91M |
Balance sheet as of Jun 30, 2026.
Cash Flow
After $17 of capital spending, operating cash flow left -$8.95M of free cash flow.
| Operating Cash Flow | -$8.95M |
|---|---|
| Capital Expenditures | $17 |
| Free Cash Flow | -$8.95M |
| FCF Per Share | -$0.66 |
| Depreciation and Amortization | $102.84K |
Trailing 12 months through Jun 30, 2026.
Margins
The operating margin is -28728.89%.
| Gross Margin | -201.98% |
|---|---|
| Operating Margin | -28728.89% |
| Pretax Margin | -27693.88% |
| Net Margin | -27695.45% |
| FCF Margin | -17581.58% |
Growth
| Book Value Per Share Growth (2Y CAGR) | -12.93% |
|---|---|
| Tangible Book Per Share Growth (2Y CAGR) | -3.92% |
Dividends and Yields
EDSA does not pay a dividend. Its free cash flow yield is -50.71%.
| FCF Yield | -50.71% |
|---|---|
| Shareholder Yield | 0.00% |
Stock Splits
The last split was a 1-for-7 reverse split on Oct 11, 2023.
| Last Split Date | Oct 11, 2023 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:7 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About EDSA
What is EDSA's market cap?
Edesa Biotech has a market cap of $25.54M. Its enterprise value, which adds debt and subtracts cash, is $15.20M.
How many shares of EDSA are outstanding?
Edesa Biotech has 9.01M shares outstanding. The count is up 28.26% from a year earlier.
Does EDSA pay a dividend?
No. Edesa Biotech does not pay a dividend.
How much debt does EDSA have?
Edesa Biotech has $0 of total debt and $10.33M of cash and equivalents, a net cash position of $10.33M.
EDSA pages: Overview, Charting, Earnings, Financials, Statistics, Competitors